You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALXN2040

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participants Trial (Rosuvastatin, ALXN2040)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Jan 23, 2023

Paroxysmal Nocturnal Hemoglobinuria, PNH, Extravascular Hemolysis Trial (Danicopan)

Available
  • Paroxysmal Nocturnal Hemoglobinuria
  • +2 more
  • (no location specified)
Aug 1, 2023

Healthy Trial in Tempe (Danicopan: Powder-In-Capsule 1, Danicopan: Powder-In-Capsule 2, Danicopan: Tablet)

Completed
  • Healthy
  • Danicopan: Powder-In-Capsule 1
  • +2 more
  • Tempe, Arizona
    Clinical Trial Site
Apr 8, 2022

Healthy Trial in Tempe (Danicopan)

Completed
  • Healthy
  • Tempe, Arizona
    Clinical Trial Site
Jan 12, 2023

Healthy Trial in Ruddington (Danicopan Modified Release Prototype 1, Danicopan Modified Release Prototype 2, Danicopan Modified

Completed
  • Healthy
  • Danicopan Modified Release Prototype 1
  • +2 more
  • Ruddington, Nottingham, United Kingdom
    Clinical Trial Site
Aug 16, 2021

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Danicopan)

Completed
Has Results
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Florence, Italy
  • +4 more
May 31, 2022

Healthy Trial in Auckland (Danicopan - Tablet, Danicopan - Softgel, Danicopan - LFC)

Completed
  • Healthy
  • Danicopan - Tablet
  • +2 more
  • Auckland, New Zealand
    Clinical Trial Site
Jun 21, 2021

C3 Glomerulopathy, C3 Glomerulonephritis, Dense Deposit Disease Trial in United Kingdom, United States (Danicopan, Placebo)

Completed
Has Results
  • C3 Glomerulopathy
  • +2 more
  • Aurora, Colorado
  • +6 more
Oct 7, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial (Danicopan)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Baltimore, Maryland
  • +4 more
Feb 1, 2023

C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Worldwide (Danicopan)

Terminated
Has Results
  • C3 Glomerulonephritis
  • +4 more
  • Birmingham, Alabama
  • +12 more
Aug 9, 2022

Healthy Trial in Tempe (Danicopan, Cyclosporine, Tacrolimus)

Completed
  • Healthy
  • Tempe, Arizona
    Clinical Trial Site
Nov 3, 2021

C3 Glomerulonephritis, Dense Deposit Disease, C3 Glomerulopathy Trial in Melbourne, Antwerpen, Leiden (Danicopan)

Completed
Has Results
  • C3 Glomerulonephritis
  • +4 more
  • Melbourne, Australia
  • +2 more
Oct 7, 2021

Healthy Trial in Tempe (Danicopan, Moxifloxacin-matching Placebo, Danicopan-matching )

Completed
  • Healthy
  • Tempe, Arizona
    Clinical Trial Site
Aug 16, 2021

Hepatic Impairment Trial in Miami, Orlando (Danicopan)

Completed
  • Hepatic Impairment
  • Miami, Florida
  • +1 more
Aug 16, 2021

Healthy Trial in Auckland (Danicopan, Placebo)

Completed
  • Healthy
  • Auckland, New Zealand
    Clinical Trial Site
May 12, 2021

Healthy Trial in Auckland ([14C]-Danicopan)

Completed
  • Healthy
  • Auckland, New Zealand
    Clinical Trial Site
May 12, 2021

Healthy Trial in Auckland (Danicopan, Midazolam, Fexofenadine)

Completed
  • Healthy
  • Auckland, New Zealand
    Clinical Trial Site
Jun 21, 2021

Healthy Trial in Auckland (Danicopan, Placebo)

Completed
  • Healthy
  • Auckland, New Zealand
    Clinical Trial Site
May 12, 2021

Healthy Trial in Brisbane (Danicopan)

Completed
  • Healthy
  • Brisbane, Australia
    Clinical Study Site
Feb 11, 2021

Healthy, Renal Dysfunction Trial in United States (Danicopan)

Completed
  • Healthy
  • Renal Dysfunction
  • Miami, Florida
  • +3 more
Jun 21, 2021

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Italy, United Kingdom, United States (Danicopan, Eculizumab)

Active, not recruiting
Has Results
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Baltimore, Maryland
  • +4 more
Aug 15, 2022